Diuretic resistance predicts mortality in patients with advanced heart failure

2002 ◽  
Vol 144 (1) ◽  
pp. 31-38 ◽  
Author(s):  
Gerald W. Neuberg ◽  
Alan B. Miller ◽  
Chris M. O'Connor ◽  
Robert N. Belkin ◽  
Peter E. Carson ◽  
...  
2021 ◽  
Vol 2 (1) ◽  
pp. 8-15
Author(s):  
Anita Surya Santoso ◽  
Mohammad Saifur Rohman ◽  
Indra Prasetya ◽  
Budi Satrijo

Advanced heart failure (HF) is used to characterized patients in HF with severe symptoms, recurrent decompensation and severe cardiac dysfunction. The prevalencekof HFkis approximatelyg1-2% of thecadult population inhdeveloped countries and it will be rising more than 10%pamongapeoplec>70ayears of age, whereas estimated theoprevalence ofcpatients with advanced HF is about 1% until 10%cof thekoverallkHFopopulation. Most ofkthe HF hospitalizationssare due to signs and symptoms of fluidcoverload.Recurrent congestionccould worsen patientssoutcomes.Loopdiureticssare recommended for thectreatmentcofkcongestionqinprHF patient. cHowever,cdiureticvresistanceeispavcommon problem issueiinpacuteqdecompensationtofcadvancedochronicrheartwfailureq(ACHF) patients and established prognostic factor. Some early reports estimated the prevalence of diuretic resistance about 20%-30% in HF population. In this review, we will be discuss how to diagnose the advancedvheartufailurepand the underlying mechanism of diuretic resistancebin HF patients. We also describe pharmacologicalvand non-pharmacologicalstrategies to overcome this issue.


2003 ◽  
Vol 2 (1) ◽  
pp. 115-116
Author(s):  
J PARISSIS ◽  
S ADAMOPOULOS ◽  
K VENETSANOU ◽  
D MENTZIKOF ◽  
K KIRANAKOS ◽  
...  

2006 ◽  
Vol 5 (1) ◽  
pp. 149-149
Author(s):  
P MONTEIRO ◽  
J JONES ◽  
F FRANCO ◽  
C BAROSA ◽  
S COSTA ◽  
...  

2003 ◽  
Vol 2 (1) ◽  
pp. 169
Author(s):  
E BEIEVGENIA ◽  
G KARATASAKISGEORGE ◽  
C SPARGIASCONSTANTINOS ◽  
G KOURGIANNIDESGEORGE ◽  
N KOUTSOGIANNISNIKOLAOS ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document